Scientists discover bacterial cause behind fatal heart complications

May 15, 2015
Scientists discover bacterial cause behind fatal heart complications

Researchers at the University of Liverpool's Institute of Infection and Global Health have discovered a key cause of life threatening heart complications, conditions that frequently follow severe infections with the bacteria responsible for pneumonia and meningitis.

Streptococcus pneumoniae is a major human pathogen and is known to be associated with increased risk of fatal complications including heart failure and heart attacks.

As Streptococcus pneumoniae is a respiratory pathogen that does not infect the heart, however, the association with heart problems has puzzled clinicians and researchers, particularly as prompt use of antibiotics does not provide any protection from cardiac complications.

Heart injury

A multidisciplinary research team, led by Professor Aras Kadioglu and Professor Cheng-Hock Toh at the University, has now shown that the cause of cardiac injury is a toxin called pneumolysin, which is released by the bacteria during infection. They found that this toxin could directly attack heart , causing injury, damage and death.

Dr Yasir Alhamdi, from the University's Institute of Infection and Global Health and lead author of the study, said: "We have discovered that the toxin pneumolysin, which is released during infection with Streptococcus pneumoniae, is the main reason why a significant number of patients develop rapidly progressive and fatal heart complications even if the bacteria does not directly infect the heart."

Importantly, the researchers also found that the use of antibiotics could exacerbate damage to cells during infection with Streptococcus pneumoniae, as antibiotic-induced bacterial death releases large amounts of pneumolysin into the blood circulation.

Engineered fats

To circumvent this problem, the team used specially engineered fat bodies, called liposomes, to bind to and neutralise pneumolysin and prevent it from damaging . Liverpool researchers had previously shown that liposome therapy could be used as a treatment against pneumonia and sepsis caused by Streptococcus pneumoniae and MRSA.

Dr Daniel Neill, who conducted the infection model work, said: "We have now shown that liposomes can also be used therapeutically to combat deadly that accompany infections caused by Streptococcus pneumoniae.

"This exciting new finding demonstrates that liposomes may also be of use in conjunction with antibiotics to mitigate the pathological effects of antibiotic-induced bacterial lysis."

Explore further: How pneumonia bacteria can compromise heart health

More information: "Circulating Pneumolysin Is a Potent Inducer of Cardiac Injury during Pneumococcal Infection." PLoS Pathog 11(5): e1004836. DOI: 10.1371/journal.ppat.1004836

Related Stories

How pneumonia bacteria can compromise heart health

September 19, 2014
Bacterial pneumonia in adults carries an elevated risk for adverse cardiac events (such as heart failure, arrhythmias, and heart attacks) that contribute substantially to mortality—but how the heart is compromised has been ...

RSV infection may be associated with higher risk for bacterial pneumonia

January 6, 2015
Two common and sometimes dangerous respiratory diseases, a viral one caused by respiratory syncytial virus (RSV), and a bacterial one caused by Streptococcus pneumoniae may be linked, suggests a study published in this week's ...

Pneumonia bacterium leaves tiny lesions in the heart, study finds

September 25, 2014
The long-observed association between pneumonia and heart failure now has more physical evidence, thanks to research in the School of Medicine at The University of Texas Health Science Center at San Antonio.

Study ties dental drugs, heart infection risk

November 18, 2014
A study suggests that curbing the routine use of preventive antibiotics before dental work may have contributed to a rise in heart valve infections in England.

Scientists discover new properties of microbes that cause common eye infection

November 12, 2014
Scientists from Massachusetts Eye and Ear/Harvard Medical School Department of Ophthalmology have used the power of new genomic technology to discover that microbes that commonly infect the eye have special, previously unknown ...

Bacterial respiratory tract colonization prior to catching the flu may protect against severe illness

July 10, 2014
Many studies have shown that more severe illness and even death are likely to result if you develop a secondary respiratory infection after developing influenza. Now, however, a team of researchers based at The Wistar Institute ...

Recommended for you

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.